title: [The nondrug treatment of patients with autonomic vascular dystonia subjected to ionizing radiation exposure as a result of the accident at the Chernobyl Atomic Electric Power Station].
abstract: The suggested mode of treatment combines the intravascular laser-light irradiation of blood with the visual analyzer exposure to light the brightness of which changes evenly and rhythmically with a frequency of 7-8 vibrations per minute (0.13 Hz). The combined use of the aforementioned exposures is justified due to the fact that exposure to both ionizing radiation and psychogenic factors play an important role in the pathogenesis of vegetovascular dystonia developing in the liquidators of the Chernobyl Atomic Power Plant breakdown. Change of lighting makes for the evolution of the inhibitory process in the cortex, has a sedative effect, attenuates the influence of psychotraumatizing factors. Intravascular laser-light irradiation of blood has a beneficial effect upon the organism's reactivity and immune system. Under the influence of the therapy adopted, all patients in present series (n = 67)--liquidators of the Chernobyl APP breakdown, suffering from VVD, demonstrated beneficial shifts both in the vegetovascular reactions and immune status, as evidenced by the analysis of the results of the presented mode of treatment in this patient population.
authors.forename: E N
authors.initials: EN
authors.lastname: Panchenko
authors.forename: S E
authors.initials: SE
authors.lastname: Kazakova
authors.forename: V M
authors.initials: VM
authors.lastname: Frolov
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Vishniakov
mesh_terms: D000328:Adult; D001342:Autonomic Nervous System Diseases / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D001769:Blood / Q000528:radiation effects; D003131:Combined Modality Therapy; D004421:Dystonia / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D005260:Female; D006801:Humans; D053685:Laser Therapy; D008297:Male; D010789:Phototherapy; D011210:Power Plants; D018788:Radioactive Hazard Release; D012074:Remission Induction; D014455:Ukraine; D014652:Vascular Diseases / Q000209:etiology / Q000276:immunology / Q000628:therapy*